Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.
Brennan PN, Tavabie OD, Li W, Marjot T, Corless L, Fallowfield JA, Jarvis H, Mansour D, McPherson S, Rosenberg W, Rockell K, Tomlinson J, Yeoman A, Tsochatzis EA, Dillon JF, Alazawi W, Abeysekera KWM. Brennan PN, et al. Among authors: fallowfield ja. Lancet Gastroenterol Hepatol. 2024 Jun;9(6):577-582. doi: 10.1016/S2468-1253(23)00453-3. Epub 2024 Feb 28. Lancet Gastroenterol Hepatol. 2024. PMID: 38428439
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.
Snowdon VK, Lachlan NJ, Hoy AM, Hadoke PW, Semple SI, Patel D, Mungall W, Kendall TJ, Thomson A, Lennen RJ, Jansen MA, Moran CM, Pellicoro A, Ramachandran P, Shaw I, Aucott RL, Severin T, Saini R, Pak J, Yates D, Dongre N, Duffield JS, Webb DJ, Iredale JP, Hayes PC, Fallowfield JA. Snowdon VK, et al. Among authors: fallowfield ja. PLoS Med. 2017 Feb 28;14(2):e1002248. doi: 10.1371/journal.pmed.1002248. eCollection 2017 Feb. PLoS Med. 2017. PMID: 28245243 Free PMC article. Clinical Trial.
Models and mechanisms of fibrosis resolution.
Snowdon VK, Fallowfield JA. Snowdon VK, et al. Among authors: fallowfield ja. Alcohol Clin Exp Res. 2011 May;35(5):794-9. doi: 10.1111/j.1530-0277.2010.01400.x. Epub 2011 Feb 1. Alcohol Clin Exp Res. 2011. PMID: 21284668 Review.
Reversal of fibrosis: no longer a pipe dream?
Fallowfield JA, Kendall TJ, Iredale JP. Fallowfield JA, et al. Clin Liver Dis. 2006 Aug;10(3):481-97, viii. doi: 10.1016/j.cld.2006.08.022. Clin Liver Dis. 2006. PMID: 17162224 Review.
Safety profile of autologous macrophage therapy for liver cirrhosis.
Moroni F, Dwyer BJ, Graham C, Pass C, Bailey L, Ritchie L, Mitchell D, Glover A, Laurie A, Doig S, Hargreaves E, Fraser AR, Turner ML, Campbell JDM, McGowan NWA, Barry J, Moore JK, Hayes PC, Leeming DJ, Nielsen MJ, Musa K, Fallowfield JA, Forbes SJ. Moroni F, et al. Among authors: fallowfield ja. Nat Med. 2019 Oct;25(10):1560-1565. doi: 10.1038/s41591-019-0599-8. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591593 Clinical Trial.
Targeted treatments for cirrhosis.
Fallowfield JA, Iredale JP. Fallowfield JA, et al. Expert Opin Ther Targets. 2004 Oct;8(5):423-35. doi: 10.1517/14728222.8.5.423. Expert Opin Ther Targets. 2004. PMID: 15469393 Review.
86 results